Literature DB >> 32089294

Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.

Ellen J Kim1, Larisa Geskin2, Joan Guitart3, Christiane Querfeld4, Michael Girardi5, Amy Musiek6, David R Mink7, Michael J Williams7, James T Angello8, William L Bailey8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32089294     DOI： 10.1016/j.jaad.2019.12.070

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  11 in total

1.  Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience.

Authors:  Tiffany J Garcia-Saleem; Connor J Stonesifer; Alexandra E Khaleel; Larisa J Geskin
Journal:  Acta Derm Venereol       Date:  2021-09-08       Impact factor: 3.875

2.  Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions.

Authors:  Marios Koumourtzis; Kyriaki Lampadaki; Maria Dalamaga; Evangelia Papadavid
Journal:  Acta Derm Venereol       Date:  2022-06-09       Impact factor: 3.875

Review 3.  Topical treatments for early-stage mycosis fungoides using Grading Recommendations Assessment, Development and Evaluation (GRADE) criteria: A systematic review.

Authors:  Ebba Wennberg; Phillip Q Richards; Paul A Bain; Victor Huang; Sydney D Sullivan; Emanual M Maverakis; Gabriel E Molina; Peggy A Wu
Journal:  JAAD Int       Date:  2021-03-11

4.  Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping Algorithms.

Authors:  Michela Meregaglia; Rosanna Tarricone
Journal:  Pharmacoecon Open       Date:  2022-02-19

5.  The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.

Authors:  Ellen J Kim; Joan Guitart; Christiane Querfeld; Michael Girardi; Amy Musiek; Oleg E Akilov; James T Angello; William L Bailey; Larisa J Geskin
Journal:  Am J Clin Dermatol       Date:  2021-03-03       Impact factor: 7.403

Review 6.  Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas.

Authors:  Taku Fujimura; Ryo Amagai; Yumi Kambayashi; Setsuya Aiba
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

7.  Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports.

Authors:  Kyriaki Lampadaki; Marios Koumourtzis; Fani Karagianni; Leonidas Marinos; Evangelia Papadavid
Journal:  Adv Ther       Date:  2021-04-30       Impact factor: 3.845

Review 8.  Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.

Authors:  Larisa J Geskin; Martine Bagot; Emmilia Hodak; Ellen J Kim
Journal:  Dermatol Ther (Heidelb)       Date:  2021-05-21

9.  Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions.

Authors:  Yun-Tsan Chang; Desislava Ignatova; Wolfram Hoetzenecker; Steve Pascolo; Christina Fassnacht; Emmanuella Guenova
Journal:  JID Innov       Date:  2021-11-25

10.  Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.

Authors:  Christiane Querfeld; Julia J Scarisbrick; Chalid Assaf; Emmanuella Guenova; Martine Bagot; Pablo Luis Ortiz-Romero; Pietro Quaglino; Erminio Bonizzoni; Emmilia Hodak
Journal:  Dermatology       Date:  2021-06-04       Impact factor: 5.366
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.